Tulane Cancer Center is a clinical research site located in New Orleans, Louisiana, United States 70112.
Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.
Tulane Cancer Center has participated in 30 clinical trials with 7 currently active.
Therapeutic areas: Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma.
Sponsors: Guardant Health, Inc., Seagen, a wholly owned subsidiary of Pfizer, Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Louisiana · View every site in New Orleans
Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Tulane Cancer Center has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tulane Cancer Center has 30 clinical trials on record, with 7 currently active. Their work covers Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma.
Tulane Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.